Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma： a Prospective Study

NCT06798363 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06798363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma： a Prospective Study
Lead sponsor
West China Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 1, 2025
Completion date
March 30, 2027
Enrollment
32 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma